INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 51 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $8,000 | – | 2,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IMS Capital Management | 391,149 | $1,056,000 | 1.00% |
ELEMENT CAPITAL MANAGEMENT LLC | 136,192 | $368,000 | 0.08% |
WELCH & FORBES LLC | 400,614 | $1,081,000 | 0.03% |
Indiana Trust & Investment Management CO | 19,250 | $52,000 | 0.03% |
FLAGSHIP HARBOR ADVISORS, LLC | 15,415 | $34,000 | 0.01% |
LMR Partners LLP | 58,775 | $159,000 | 0.01% |
BOSTON FINANCIAL MANGEMENT LLC | 49,175 | $133,000 | 0.01% |
HYMAN CHARLES D | 30,000 | $81,000 | 0.01% |
Baker Brothers Advisors | 400,000 | $1,080,000 | 0.01% |
OneDigital Investment Advisors LLC | 8,911 | $24,000 | 0.01% |